Serological tests for antibodies specific for Epstein-Barr virus (EBV) antigens are frequently
used to define infection status and for the differential diagnosis of other pathogens …

Epstein Barr virus (EBV) is a cosmopolitan oncogenic virus, infecting about 90% of the
world's population and it is associated to tumors originating from both epithelia and …

The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

6.1. Background The incidence of tuberculosis (TB) is a concern at the start of the third
millennium, particularly with the increase of multiresistant (MDR-TB) and extended resistant …

Multiple sclerosis (MS) is a chronic neuroinflammatory condition of the central nervous
system (CNS). It is a major cause of neurological disability in young adults, particularly …

Multiple sclerosis (MS) is a common, complex neurological disease. Epidemiological data
implicate both genetic and environmental factors in the etiology of MS, with various factors …

Nasopharyngeal carcinoma (NPC) is a head and neck cancer rare throughout most of the
world but common in certain geographic areas, such as southern Asia. While environmental …

Since the initial report of unusual manifestations possibly associated with chronic active
Epstein‐Barr virus (EBV) infection (CAEBV), nearly three decades have passed. During this …

In 1968 Epstein-Barr virus (EBV; now human herpesvirus 4) was found to be the major
cause of infectious mononucleosis (IM), a usually self-limited clinical syndrome (10). Only …

Epstein–Barr virus (EBV) is implicated as an aetiological factor in B lymphomas and
nasopharyngeal carcinoma. The mechanisms of cell-free EBV infection of nasopharyngeal …